Chennai: A new AI-enabled deep brain stimulation (DBS) device, one that can read brain signals and adjust itself, will be ...
“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...
In collaboration with its newly minted Chinese partner, Kiwi drug developer and marketer AFT Pharmaceuticals (ASX:AFP) plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback